The epigenetic mechanism of folic acid (FA) action on dorsal root ganglion (DRG) cell proliferation and sensory neuron differentiation is not well understood. In this study, the ND7 cell line, derived from DRG cells, was used to elucidate this mechanism. In ND7 cells differentiated with dbcAMP and NGF, Hes1 and Pax3 levels decreased, whereas Neurog2 levels showed a modest increase. Chromatin immunoprecipitation (ChIP) assays examining epigenetic marks at the Hes1 promoter showed that FA favored increased H3K9 and H3K19 acetylation and decreased H3K27 methylation. Hence, FA plays a positive role in cell proliferation. In differentiated ND7 cells, H3K27 methylation decreased, whereas H3K9 and H3K18 acetylation increased at the Neurog2 promoter. FA did not favor this phenotypic outcome. Additionally, in differentiated ND7 Neurog2 associated with the NeuroD1 promoter, FA decreased this association. The results suggest that the switch from proliferation to sensory neuron differentiation in DRG cells is regulated by alterations in epigenetic marks, H3K9/18 acetylation and H3K27 methylation, at Hes1 and Neurog2 promoters, as well as by Neurog2 association with NeuroD1 promoter. FA although positive for proliferation, does not appear to play a role in differentiation.

Download full-text PDF

Source
http://dx.doi.org/10.4161/epi.6.10.17592DOI Listing

Publication Analysis

Top Keywords

h3k27 methylation
12
dorsal root
8
root ganglion
8
folic acid
8
cell proliferation
8
proliferation sensory
8
sensory neuron
8
neuron differentiation
8
drg cells
8
nd7 cells
8

Similar Publications

KDM6A facilitates Xist upregulation at the onset of X inactivation.

Biol Sex Differ

January 2025

Department of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, 98195, USA.

Background: X chromosome inactivation (XCI) is a female-specific process in which one X chromosome is silenced to balance X-linked gene expression between the sexes. XCI is initiated in early development by upregulation of the lncRNA Xist on the future inactive X (Xi). A subset of X-linked genes escape silencing and thus have higher expression in females, suggesting female-specific functions.

View Article and Find Full Text PDF

G9a/GLP Modulators: Inhibitors to Degraders.

J Med Chem

January 2025

SANKEN, Osaka University, Mihogaoka, Ibaraki-shi, Osaka 567-0047, Japan.

Article Synopsis
  • Histone methylation is a key part of epigenetics, involving enzymes like G9a that modify histones and regulate DNA processes such as replication and gene expression.
  • Overexpression of G9a is linked to cancer development and progression, making it an appealing target for new cancer therapies.
  • Research is also uncovering the role of G9a in diseases like Alzheimer's, leading to the development of G9a inhibitors that could treat various conditions by disrupting harmful signaling pathways.
View Article and Find Full Text PDF

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), is a long non-coding RNA localized in the cell nucleus, known for its multifunctional roles, including potential involvement in spermatogenesis. This study investigates the mechanism by which MALAT1 dysregulation contributes to the pathogenesis of idiopathic non-obstructive azoospermia (iNOA). We analyzed MALAT1 levels in two gene expression profiling datasets comprising patients with obstructive azoospermia (OA) who have normal spermatogenesis and 13 patients with iNOA.

View Article and Find Full Text PDF

Histone methyltransferase NSD2 (MMSET) overexpression in multiple myeloma (MM) patients plays an important role in the development of this disease subtype. Through the expansion of transcriptional activating H3K36me2 and the suppression of repressive H3K27me3 marks, NSD2 activates an aberrant set of genes that contribute to myeloma growth, adhesive and invasive activities. NSD2 transcriptional activity also depends on its non-catalytic domains, which facilitate its recruitment to chromatin through histone binding.

View Article and Find Full Text PDF
Article Synopsis
  • - Colorectal cancer (CRC) is a major health concern globally, with miR-137 identified as a crucial tumor suppressor that is often silenced through methylation and H3K27 trimethylation by EZH2.
  • - Research indicates that the frequent methylation of miR-137 in CRC is linked to decreased expression, which can be reversed, enhancing its potential as a therapeutic target.
  • - miR-137 plays a significant role in inhibiting CRC cell behavior and regulates the Wnt signaling pathway by targeting RNF4, ultimately leading to destabilization of key proteins like c-Myc and β-catenin, which are involved in tumor growth.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!